We are live on
!
Find out more
CO
Caldwell & Orkin Portfolio holdings
AUM
$98.3M
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+8.46%
1 Year Est. Return
+37.67%
3 Year Est. Return
+137.01%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$116M
(+73%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
41.52%
Top 10 Holdings %
Top 10 Hldgs %
34.87%
Holding
97
New
29
Increased
20
Reduced
16
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Company
SO
|
+$8.33M |
| 2 |
GE Aerospace
GE
|
+$8.13M |
| 3 |
Microsoft
MSFT
|
+$6.69M |
| 4 |
FL
Foot Locker
FL
|
+$5.58M |
| 5 |
Aramark
ARMK
|
+$5.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$5.38M |
| 2 |
Target
TGT
|
+$4.03M |
| 3 |
Comcast
CMCSA
|
+$3.45M |
| 4 |
Darden Restaurants
DRI
|
+$2.35M |
| 5 |
Apple
AAPL
|
+$2.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.17% |
| 2 | Consumer Discretionary | 17.17% |
| 3 | Consumer Staples | 9.01% |
| 4 | Technology | 5.16% |
| 5 | Communication Services | 4.74% |
Similar funds
MRFOFM
CRIM
NFM
SCP
PCMM
OCM
RCM
GS
Caldwell & Orkin's Q4 2015 Portfolio in Review
As of Q4 2015, Caldwell & Orkin held 97 positions worth $273M, up 73% from $157M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Caldwell & Orkin deployed $113M of net new capital in Q4 2015, opening 29 new positions and adding to 20 existing holdings. Its largest new stake was Southern Company: 183,725 shares worth $8.6M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Target, an estimated $4.03M trimmed.
- Caldwell & Orkin's largest Q4 2015 buy was Southern Company: 183,725 shares worth $8.6M.
- Caldwell & Orkin added most to Microsoft in Q4 2015, an estimated $6.69M increase.
- Caldwell & Orkin's biggest Q4 2015 reduction was Target, cutting an estimated $4.03M.
- Caldwell & Orkin fully exited CVS Health in Q4 2015, selling an estimated $5.38M.
- Caldwell & Orkin's ten largest holdings make up 35% of its $273M portfolio in Q4 2015.
- Caldwell & Orkin opened 29 new positions and closed 23 in Q4 2015.
- Caldwell & Orkin's portfolio value rose 73% quarter-over-quarter to $273M.
Based on Caldwell & Orkin's 13F filing for Q4 2015, filed 10 Feb 2016.